2 stays of 10 nights & 5 OPVs

8472-370 3d 3d

Back To Current Studies

2 stays of 10 nights & 5 OPVs

Study Number

8472-370 3d

Group

3d

Gender

both

Age

40 - 65

Location

Dallas, Texas

Compensation

$11,744

Study Dates

Feb. 12 - Mar. 27, 2023

Additional Information

The investigational drug in this research study is being developed for the treatment of breast cancer.

Labcorp Dallas, TX is recruiting for:

- Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 40-65

- Body Mass Index between 18-32

- Study involves 2 stays of 10 nights and 5 follow-up visits

- Compensation up to $11,744 may be provided for time and participation

- Receive up to $350 per qualified participant

Details

The purpose of Cohort 3 of this study is to measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it.

Group 3d:

Check-In: Feb 12, Mar 5

Check-Out: Feb 22, Mar 15

Outpatient Visit : Feb 27, Mar, 3, 20, 24, 27

 

OR

Group 3g:

Check-In: Feb 23, Mar 16

Check-Out: Mar 5, Mar 26

Outpatient Visit : Mar, 10, 14, 31, Apr 4, 7

 

Calculate Your BMI!

Your Height:
ft / in
Your Weight:
lbs
Select Measurement System:

Your BMI: result